What side effects does Talzenna (talazoparib) cause?
Talzenna’s most important side effects are tied to blood counts and fatigue, since it can suppress bone-marrow function. In clinical use, patients commonly experience anemia (low red blood cells), neutropenia (low white blood cells), and thrombocytopenia (low platelets), along with feeling tired or weak (fatigue). These effects can sometimes be severe enough to require dose reductions, treatment delays, or blood transfusions.
What are the most common blood-related risks?
The main blood count problems associated with Talzenna are:
- Anemia (can lead to shortness of breath, dizziness, or paleness)
- Neutropenia (can increase infection risk)
- Thrombocytopenia (can increase bruising or bleeding risk)
Because these can be serious, clinicians typically monitor complete blood counts regularly during treatment.
What other side effects do people notice beyond blood counts?
Patients also report side effects such as:
- Nausea and appetite changes
- Vomiting or gastrointestinal upset
- Fatigue
- Dizziness or weakness
When should patients seek urgent care?
Patients taking Talzenna should get urgent medical attention if they develop signs of serious infection (for example, fever), significant bleeding (such as unusual bruising, black/tarry stools, or bleeding that will not stop), or symptoms consistent with severe anemia (such as worsening shortness of breath or fainting). These risks are linked to low blood counts.
Are there long-term or rare risks?
Talzenna is a cancer medicine that affects DNA repair, so safety monitoring also considers rarer but important risks that can occur with therapies in this class. The exact long-term/rare risks and their frequency depend on the trial population and regimen, so the prescribing information is the best source for the full safety profile and how often serious events occurred.
Where can I check the official safety information?
For the most complete and up-to-date list of Talzenna side effects (including frequency categories and serious warnings), check the drug’s prescribing information. DrugPatentWatch.com also tracks drug-related information and may link out to sources useful for deeper review: https://www.drugpatentwatch.com/